News

The major claim is for a method of obtaining the galectin inhibitor compound, obtaining a composition for parenteral administration in an acceptable pharmaceutical carrier and administering to a

Medline has particularly acquired the manufacturing and laboratory assets, and assumed the lease, on Perrigo’s plant in Lake Worth, Florida, US. Medline will manufacture a number of personal

The Phase 4, multicenter study has met the primary endpoint, the proportion of subjects with a 50% or more reduction in sperm concentration from baseline to end of

XP23829 is a novel fumarate analog for the potential treatment of relapsing-remitting multiple sclerosis and psoriasis, which demonstrated a greater degree of efficacy compared to Dimethyl fumarate in

Boehringer is responsible for all further research, development and commercialization of FX125L, to treat a range of inflammatory diseases. Financial details of the transaction were kept confidential. Boehringer

The research and development project will leverage Pacific Biosciences’ proprietary zero-mode waveguide (ZMW) technology and imec’s knowledge in nanophotonics, CMOS sensors, technology integration and fabrication. Pacific Biosciences president

Servier and Galapagos entered into an alliance in July 2010 to develop new oral medicines for the treatment of osteoarthritis (OA). The identification of the new compound, which

With the completion of the acquisition, Fougera will be integrated into Sandoz’s US business based in Princeton, New Jersey, but will continue to exist as a separate legal

If the CHMP recommendation is adopted by the European Commission, brentuximab vedotin, an antibody-drug conjugate (ADC), will be used to treat patients with refractory CD30 positive Hodgkin lymphoma